Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations

v3.19.2
Discontinued Operations
6 Months Ended
Jun. 30, 2019
Discontinued Operations  
Discontinued Operations

Note 3 – Discontinued Operations

On January 2, 2019, the Board approved a strategic shift to focus on the commercialization of its B-TRAN™ technology and a plan to suspend further power converter system development and sales while the Company located a buyer for its power conversion systems division. On January 4, 2019, the Company implemented a reduction-in-force in connection with this exit activity and recognized an expense of $92,600 in involuntary termination benefits.

The Company’s power conversion system division, a component supplier to energy storage system integrators, had not achieved the necessary scale to generate positive cash flows. As the division was dependent on the ability of its customers to scale in the small commercial and industrial segment of the energy storage market and based on the sales forecasts and commitments provided by these customers, the Company did not expect its power conversion systems division to scale sufficiently in the short term, requiring an inflow of additional capital for the business. As such, the decision was made to exit the power conversion systems business and sell the division and the Company’s PPSA™ technology and focus on the Company’s B-TRAN™ technology.

As a result, the assets held for sale and discontinued operations criteria were met and the Company’s financial statements are presented in accordance with ASC 205. Under ASC 205‑20‑45‑10, during the period in which a component meets the assets held for sale and discontinued operations criteria, an entity must present the assets and liabilities of the discontinued operation separately in the asset and liability sections of the balance sheet for the comparative reporting periods. The prior period balance sheet should be reclassified for the held for sale items. For income statements, the current and prior periods should report the results of operations of the component in discontinued operations when comparative income statements are presented.

The following is a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:

 

 

 

 

 

 

 

 

    

June 30, 

    

December 31, 

 

 

2019

 

2018

Accounts receivable, net

 

$

2,500

 

$

270,768

Inventories, net

 

 

129,017

 

 

131,342

Prepayments and other current assets

 

 

6,182

 

 

22,322

Property and equipment, net (1)

 

 

255,709

 

 

329,738

Intangible assets, net (1)

 

 

 —

 

 

342,153

Current assets held for sale (2)

 

$

393,408

 

$

1,096,323

 

 

 

 

 

 

 

Accounts payable

 

$

8,199

 

$

356,113

Accrued expenses

 

 

465,487

 

 

521,642

Current liabilities held for sale

 

$

473,686

 

$

877,755


(1)

Includes an impairment charge of $765,000 of which $405,000 was recognized during the six months ended June 30, 2019, calculated as the net book value of assets held for sale prior to the impairment less the expected  net proceeds from the planned sale. The expected net proceeds are based on the estimated fair value of the net assets held for sale less the estimated cost to sell the net assets held for sale.

(2)

The assets of the discontinued operations classified as held for sale are classified as current on the June 30, 2019 and December 31, 2018 balance sheets because it is probable that the sale will occur and proceeds will be collected within one year.

The following is a reconciliation of the major classes of line items constituting loss from discontinued operations to loss from discontinued operations shown in the Statement of Operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

June 30, 

 

June 30, 

 

 

2019

 

2018

 

2019

 

2018

Revenue

    

$

1,500

    

$

619,942

    

$

115,000

    

$

801,442

Cost of revenue

 

 

41,542

 

 

584,800

 

 

140,310

 

 

919,763

Research and development

 

 

24,766

 

 

583,323

 

 

185,050

 

 

1,246,562

General and administrative

 

 

13,468

 

 

14,360

 

 

38,974

 

 

24,249

Sales and marketing

 

 

(1,200)

 

 

69,989

 

 

34,917

 

 

324,232

Impairment (1)

 

 

265,000

 

 

 —

 

 

405,000

 

 

 —

Loss from discontinued operations

 

$

(342,076)

 

$

(632,530)

 

$

(689,251)

 

$

(1,713,364)


(1)

Impairment charge was calculated as the net book value of assets held for sale prior to the impairment less the expected net proceeds from the planned sale. The expected net proceeds are based on the estimated fair value of the net assets held for sale less the estimated cost to sell the net assets held for sale.